Company

Company

Protip Medical is a company created around the ambitious project of developing a range of medical devices that address the problem of dysphagia.

Through the years and re-iteration of the design of its products, used for the moment exclusively in the frame of controlled clinical trials, Protip has developed a real expertise around the pathologies of swallowing.

Protip developed also SWALL-E, a robot that we use for research and that will be available for rheologic tests.

Thanks to our expertise in translational research and the availability of skilled resources, Protip is part of international collaborative projects around the design of new biomaterials for the entire implant industry, as in the Immodgel project and the Panbiora project.

Benefiting from this multidisciplinary team, we are passionate about our mission and committed to success.

Do not hesitate to consult our latest news.

vignette-management

Linda NICOLINI,
CEO

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

vignette-management

Nihal Engin VRANA,
PhD, VP Scientific Affairs

Nihal Engin obtained his PhD in 2009 from Dublin City University as a Marie Curie ESR fellow. He holds an M.Sc. in Biotechnology and B.Sc. in Biology (both from Middle East Technical University, where he also studied Civil Engineering). His major research interests are titanium implants, immune responses to implants, real-time monitoring of implants, tissue engineering, cell encapsulation and cell biomaterials interactions. He currently coordinates the FP7 project Immodgel. He has published 29 articles in peer-reviewed academic journals, 4 book chapters and holds 2 European patents. His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012).

vignette-management

Nicolas PERRIN,
PhD, VP Scientific Affairs

Nihal Engin obtained his PhD in 2009 from Dublin City University as a Marie Curie ESR fellow. He holds an M.Sc. in Biotechnology and B.Sc. in Biology (both from Middle East Technical University, where he also studied Civil Engineering). His major research interests are titanium implants, immune responses to implants, real-time monitoring of implants, tissue engineering, cell encapsulation and cell biomaterials interactions. He currently coordinates the FP7 project Immodgel. He has published 29 articles in peer-reviewed academic journals, 4 book chapters and holds 2 European patents. His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012).

vignette-management

Yo FUJISO,
PhD, Engineer R&D

Nihal Engin obtained his PhD in 2009 from Dublin City University as a Marie Curie ESR fellow. He holds an M.Sc. in Biotechnology and B.Sc. in Biology (both from Middle East Technical University, where he also studied Civil Engineering). His major research interests are titanium implants, immune responses to implants, real-time monitoring of implants, tissue engineering, cell encapsulation and cell biomaterials interactions. He currently coordinates the FP7 project Immodgel. He has published 29 articles in peer-reviewed academic journals, 4 book chapters and holds 2 European patents. His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012).

vignette-management

Julian van der Giessen,
PhD, Engineer R&D

Nihal Engin obtained his PhD in 2009 from Dublin City University as a Marie Curie ESR fellow. He holds an M.Sc. in Biotechnology and B.Sc. in Biology (both from Middle East Technical University, where he also studied Civil Engineering). His major research interests are titanium implants, immune responses to implants, real-time monitoring of implants, tissue engineering, cell encapsulation and cell biomaterials interactions. He currently coordinates the FP7 project Immodgel. He has published 29 articles in peer-reviewed academic journals, 4 book chapters and holds 2 European patents. His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012).

vignette-management

Julian van der Giessen,
PhD, Engineer R&D

Nihal Engin obtained his PhD in 2009 from Dublin City University as a Marie Curie ESR fellow. He holds an M.Sc. in Biotechnology and B.Sc. in Biology (both from Middle East Technical University, where he also studied Civil Engineering). His major research interests are titanium implants, immune responses to implants, real-time monitoring of implants, tissue engineering, cell encapsulation and cell biomaterials interactions. He currently coordinates the FP7 project Immodgel. He has published 29 articles in peer-reviewed academic journals, 4 book chapters and holds 2 European patents. His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012).